Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Fisher

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Rheumatology (Oxford, England)|March 3, 2023
A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sjögren's syndromeDarren Bentley, Benjamin A Fisher, Francesca Barone, et al.
Clinical Rheumatology|August 22, 2008
Prevalence of subjective voice impairment in rheumatoid arthritisBenjamin A Fisher, Kathleen Dolan, Lesley Hastings, et al.
The Journal of Rheumatology|April 3, 2012
Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritisBenjamin A Fisher, Darren Plant, Karin Lundberg, et al.
Rheumatology (Oxford, England)|August 29, 2015
Quantitative power Doppler ultrasound measures of peripheral joint synovitis in poor prognosis early rheumatoid arthritis predict radiographic progressionDee Sreerangaiah, Michael Grayer, Benjamin A Fisher, et al.
Clinical Medicine (London, England)|August 7, 2025
Immune checkpoint inhibitor-induced inflammatory arthritisBenjamin A Fisher, Andrew Allard, Shirish Dubey, et al.
RMD Open|March 4, 2026
Impact of socioeconomic deprivation on risk and disease activity of Sjögren's diseaseAliaksandra Baranskaya, Matilde Bandeira, Abdullah Nadeem, et al.
Communications Medicine|June 19, 2026
Clinical features and pathogenesis of Sjogrens disease related peripheral neuropathy and their relevance to clinical trialsValentina Pucino, Saba Nayar, Janev Fehmi, et al.
Clinical and Experimental Rheumatology|December 27, 2023
The impact of concomitant Sjögren's disease on rheumatoid arthritis disease activity: a systematic review and meta-analysisTakuya Tomizawa, Tobias Cox, Florian Kollert, et al.
Arthritis Research & Therapy|March 14, 2024
Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohortLisa Christ, Seraphina Kissling, Axel Finckh, et al.
Plos One|November 1, 2017
A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's SyndromeRebecca J Stack, Sue Southworth, Benjamin A Fisher, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Rheumatology (Oxford, England)|March 3, 2023
A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sjögren's syndromeDarren Bentley, Benjamin A Fisher, Francesca Barone, et al.
Clinical Rheumatology|August 22, 2008
Prevalence of subjective voice impairment in rheumatoid arthritisBenjamin A Fisher, Kathleen Dolan, Lesley Hastings, et al.
The Journal of Rheumatology|April 3, 2012
Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritisBenjamin A Fisher, Darren Plant, Karin Lundberg, et al.
Rheumatology (Oxford, England)|August 29, 2015
Quantitative power Doppler ultrasound measures of peripheral joint synovitis in poor prognosis early rheumatoid arthritis predict radiographic progressionDee Sreerangaiah, Michael Grayer, Benjamin A Fisher, et al.
Clinical Medicine (London, England)|August 7, 2025
Immune checkpoint inhibitor-induced inflammatory arthritisBenjamin A Fisher, Andrew Allard, Shirish Dubey, et al.
RMD Open|March 4, 2026
Impact of socioeconomic deprivation on risk and disease activity of Sjögren's diseaseAliaksandra Baranskaya, Matilde Bandeira, Abdullah Nadeem, et al.
Communications Medicine|June 19, 2026
Clinical features and pathogenesis of Sjogrens disease related peripheral neuropathy and their relevance to clinical trialsValentina Pucino, Saba Nayar, Janev Fehmi, et al.
Clinical and Experimental Rheumatology|December 27, 2023
The impact of concomitant Sjögren's disease on rheumatoid arthritis disease activity: a systematic review and meta-analysisTakuya Tomizawa, Tobias Cox, Florian Kollert, et al.
Arthritis Research & Therapy|March 14, 2024
Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohortLisa Christ, Seraphina Kissling, Axel Finckh, et al.
Plos One|November 1, 2017
A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's SyndromeRebecca J Stack, Sue Southworth, Benjamin A Fisher, et al.
Pageof 9